Breast malignancy. Malignant neoplasm of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: consent for using the cap and filling on the questionnaire using chemotherapy regimens resulting in total alopecia including: 1. Doxorobicin plus cyclophosphamide followed by one of the Taxane drugs (in one, two or three-week regimens) 2. BEP regimen in gonadal malignanciy 3. FEC (5Fu-Epirubicin -cyclophosphamaid) regimen 4. VAC (vincristin-Doxorobicin -cyclophosphamaid) regimen in sarcomas performance higher than 70% age between 18 to 75 years
Exclusion criteria
Exclusion criteria: Melanoma Blood malignancies Liver or kidney dysfunction Migraine History of cryoglobulinemia Systemic lupus erythematosus No consent for using the caps
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alopecia. Timepoint: prior to each chemotherapy cycle. Method of measurement: visual inspection and questionnaire based on WHO alopecia grading. | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache. Timepoint: following every cycle of chemotherapy. Method of measurement: qestionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences